US Stock MarketDetailed Quotes

CNTA Centessa Pharmaceuticals

Watchlist
  • 17.910
  • +0.310+1.76%
Close Nov 29 13:00 ET
  • 18.200
  • +0.290+1.62%
Post 16:24 ET
2.36BMarket Cap-11782P/E (TTM)

Centessa Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
6.85M
6.85M
0
0
0
0
0
Operating revenue
--0
--0
--0
--6.85M
--6.85M
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
15.41%46.41M
-6.46%43.98M
-26.16%36.09M
-15.29%178.14M
1.03%42.03M
-17.99%40.21M
-31.27%47.02M
-4.61%48.88M
210.28M
41.6M
Selling and administrative expenses
4.02%12.5M
-16.34%11.17M
-16.28%13.44M
-2.66%53.73M
-10.55%12.32M
-2.16%12.02M
-9.60%13.35M
11.58%16.05M
--55.2M
--13.77M
-General and administrative expense
4.02%12.5M
-16.34%11.17M
-16.28%13.44M
-2.66%53.73M
-10.55%12.32M
-2.16%12.02M
-9.60%13.35M
11.58%16.05M
--55.2M
--13.77M
Research and development costs
20.27%33.9M
-2.55%32.82M
-30.99%22.65M
-19.78%124.41M
6.76%29.72M
-23.28%28.19M
-37.24%33.67M
-10.93%32.83M
--155.08M
--27.84M
Operating profit
-15.41%-46.41M
6.46%-43.98M
26.16%-36.09M
18.55%-171.28M
15.44%-35.18M
17.99%-40.21M
31.27%-47.02M
4.61%-48.88M
-210.28M
-41.6M
Net non-operating interest income expense
90.05%783K
282.86%715K
-66.67%62K
108.10%570K
116.77%363K
122.33%412K
75.98%-391K
113.32%186K
-7.03M
-2.16M
Non-operating interest income
13.11%3.34M
57.36%3.24M
2.37%2.59M
4,193.44%10.48M
7,420.51%2.93M
3,735.06%2.95M
8,136.00%2.06M
2,333.65%2.53M
--244K
--39K
Non-operating interest expense
0.63%2.56M
3.06%2.53M
7.85%2.53M
36.13%9.91M
16.66%2.57M
32.21%2.54M
48.22%2.45M
56.33%2.35M
--7.28M
--2.2M
Other net income (expense)
318.49%3.66M
110.09%154K
-14.19%-1.54M
-1,599.45%-5.43M
-1,154.29%-878K
46.64%-1.68M
-128.49%-1.53M
24.55%-1.35M
362K
-70K
Special income (charges)
----
----
----
--0
----
----
----
----
---1.98M
--0
-Less：Restructuring and merger&acquisition
----
----
----
--0
----
----
----
----
--1.98M
--0
Other non- operating income (expenses)
318.49%3.66M
110.09%154K
-14.19%-1.54M
-331.77%-5.43M
-1,154.29%-878K
46.64%-1.68M
-128.49%-1.53M
-786.73%-1.35M
--2.34M
---70K
Income before tax
-1.17%-41.96M
11.91%-43.11M
24.93%-37.57M
18.81%-176.14M
18.58%-35.69M
23.22%-41.47M
24.34%-48.94M
8.05%-50.04M
-216.95M
-43.84M
Income tax
121.51%608K
102.93%705K
-28.95%481K
-3,254.22%-25.06M
272.29%1.14M
-1,904.26%-2.83M
-109,222.73%-24.05M
746.25%677K
-747K
-664K
Net income
-10.14%-42.57M
-76.07%-43.82M
24.98%-38.05M
30.12%-151.09M
14.68%-36.84M
28.26%-38.65M
61.51%-24.89M
6.94%-50.71M
-216.21M
-43.17M
Net income continuous Operations
-10.14%-42.57M
-76.07%-43.82M
24.98%-38.05M
30.12%-151.09M
14.68%-36.84M
28.26%-38.65M
61.51%-24.89M
6.94%-50.71M
---216.21M
---43.17M
Minority interest income
Net income attributable to the parent company
-10.14%-42.57M
-76.07%-43.82M
24.98%-38.05M
30.12%-151.09M
14.68%-36.84M
28.26%-38.65M
61.51%-24.89M
6.94%-50.71M
-216.21M
-43.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-10.14%-42.57M
-76.07%-43.82M
24.98%-38.05M
30.12%-151.09M
14.68%-36.84M
28.26%-38.65M
61.51%-24.89M
6.94%-50.71M
-216.21M
-43.17M
Basic earnings per share
7.50%-0.37
-53.85%-0.4
28.30%-0.38
32.03%-1.57
17.78%-0.37
29.82%-0.4
62.32%-0.26
11.67%-0.53
-2.31
33.82%-0.45
Diluted earnings per share
7.50%-0.37
-53.85%-0.4
28.30%-0.38
32.03%-1.57
17.78%-0.37
29.82%-0.4
62.32%-0.26
11.67%-0.53
-2.31
33.82%-0.45
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0006.85M6.85M00000
Operating revenue --0--0--0--6.85M--6.85M--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 15.41%46.41M-6.46%43.98M-26.16%36.09M-15.29%178.14M1.03%42.03M-17.99%40.21M-31.27%47.02M-4.61%48.88M210.28M41.6M
Selling and administrative expenses 4.02%12.5M-16.34%11.17M-16.28%13.44M-2.66%53.73M-10.55%12.32M-2.16%12.02M-9.60%13.35M11.58%16.05M--55.2M--13.77M
-General and administrative expense 4.02%12.5M-16.34%11.17M-16.28%13.44M-2.66%53.73M-10.55%12.32M-2.16%12.02M-9.60%13.35M11.58%16.05M--55.2M--13.77M
Research and development costs 20.27%33.9M-2.55%32.82M-30.99%22.65M-19.78%124.41M6.76%29.72M-23.28%28.19M-37.24%33.67M-10.93%32.83M--155.08M--27.84M
Operating profit -15.41%-46.41M6.46%-43.98M26.16%-36.09M18.55%-171.28M15.44%-35.18M17.99%-40.21M31.27%-47.02M4.61%-48.88M-210.28M-41.6M
Net non-operating interest income expense 90.05%783K282.86%715K-66.67%62K108.10%570K116.77%363K122.33%412K75.98%-391K113.32%186K-7.03M-2.16M
Non-operating interest income 13.11%3.34M57.36%3.24M2.37%2.59M4,193.44%10.48M7,420.51%2.93M3,735.06%2.95M8,136.00%2.06M2,333.65%2.53M--244K--39K
Non-operating interest expense 0.63%2.56M3.06%2.53M7.85%2.53M36.13%9.91M16.66%2.57M32.21%2.54M48.22%2.45M56.33%2.35M--7.28M--2.2M
Other net income (expense) 318.49%3.66M110.09%154K-14.19%-1.54M-1,599.45%-5.43M-1,154.29%-878K46.64%-1.68M-128.49%-1.53M24.55%-1.35M362K-70K
Special income (charges) --------------0-------------------1.98M--0
-Less：Restructuring and merger&acquisition --------------0------------------1.98M--0
Other non- operating income (expenses) 318.49%3.66M110.09%154K-14.19%-1.54M-331.77%-5.43M-1,154.29%-878K46.64%-1.68M-128.49%-1.53M-786.73%-1.35M--2.34M---70K
Income before tax -1.17%-41.96M11.91%-43.11M24.93%-37.57M18.81%-176.14M18.58%-35.69M23.22%-41.47M24.34%-48.94M8.05%-50.04M-216.95M-43.84M
Income tax 121.51%608K102.93%705K-28.95%481K-3,254.22%-25.06M272.29%1.14M-1,904.26%-2.83M-109,222.73%-24.05M746.25%677K-747K-664K
Net income -10.14%-42.57M-76.07%-43.82M24.98%-38.05M30.12%-151.09M14.68%-36.84M28.26%-38.65M61.51%-24.89M6.94%-50.71M-216.21M-43.17M
Net income continuous Operations -10.14%-42.57M-76.07%-43.82M24.98%-38.05M30.12%-151.09M14.68%-36.84M28.26%-38.65M61.51%-24.89M6.94%-50.71M---216.21M---43.17M
Minority interest income
Net income attributable to the parent company -10.14%-42.57M-76.07%-43.82M24.98%-38.05M30.12%-151.09M14.68%-36.84M28.26%-38.65M61.51%-24.89M6.94%-50.71M-216.21M-43.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -10.14%-42.57M-76.07%-43.82M24.98%-38.05M30.12%-151.09M14.68%-36.84M28.26%-38.65M61.51%-24.89M6.94%-50.71M-216.21M-43.17M
Basic earnings per share 7.50%-0.37-53.85%-0.428.30%-0.3832.03%-1.5717.78%-0.3729.82%-0.462.32%-0.2611.67%-0.53-2.3133.82%-0.45
Diluted earnings per share 7.50%-0.37-53.85%-0.428.30%-0.3832.03%-1.5717.78%-0.3729.82%-0.462.32%-0.2611.67%-0.53-2.3133.82%-0.45
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data